Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. [electronic resource]
Producer: 20081224Description: 1843-50 p. digitalISSN:- 1522-9645
- Angioplasty, Balloon, Coronary -- adverse effects
- Biomarkers -- blood
- Coronary Angiography
- Coronary Circulation -- drug effects
- Electrocardiography
- Endothelin-1 -- blood
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- blood
- No-Reflow Phenomenon -- blood
- Risk Assessment
- Thromboxane A2 -- blood
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.